Myocardial Viability As Integral Part of the Diagnostic and Therapeutic Approach to Ischemic Heart Failure

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2015 Mar 4

PMID 25733105

Citations 15

Authors

Jeroen J Bax

Victoria Delgado

Affiliations

Soon will be listed here.

Abstract

Chronic heart failure is a major public-health problem with a high prevalence, complex treatment, and high mortality. A careful and comprehensive analysis is needed to provide optimal (and personalized) therapy to heart failure patients. The main 4 non-invasive imaging techniques (echocardiography, magnetic resonance imaging, multi-detector-computed tomography, and nuclear imaging) provide information on cardiovascular anatomy and function, which form the basis of the assessment of the pathophysiology underlying heart failure. The selection of imaging modalities depends on the information that is needed for the clinical management of the patients: (1) underlying etiology (ischemic vs non-ischemic); (2) in ischemic patients, need for revascularization should be evaluated (myocardial ischemia/viability?); (3) left ventricular function and shape assessment; (4) presence of significant secondary mitral regurgitation; (5) device therapy with cardiac resynchronization therapy and/or implantable cardiac defibrillator (risk of sudden cardiac death). This review is dedicated to assessment of myocardial viability, however "isolated assessment of myocardial viability" may be clinically not meaningful and should be considered among all those different variables. This complete information will enable personalized treatment of the patient with ischemic heart failure.

Citing Articles

The complex role of cardiovascular imaging in viability testing.

Nealy Z, Wang S, Patel A Prog Cardiovasc Dis. 2025; 88:113-125.

PMID: 39788340 PMC: 11835452. DOI: 10.1016/j.pcad.2024.12.008.

Ischaemic and viability testing for guiding PCI are overrated: pros and cons.

McEntegart M, Oksnes A, Carrillo X, Delgado V EuroIntervention. 2024; 20(6):e341-e343.

PMID: 38506743 PMC: 10941666. DOI: 10.4244/EIJ-E-24-00005.

Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities.

Baglini E, Poggetti V, Cavallini C, Petroni D, Forini F, Nicolini G J Med Chem. 2023; 67(1):17-37.

PMID: 38113353 PMC: 10911791. DOI: 10.1021/acs.jmedchem.3c01716.

Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure.

Balogh V, MacAskill M, Hadoke P, Gray G, Tavares A Front Cardiovasc Med. 2021; 8():719031.

PMID: 34485416 PMC: 8416043. DOI: 10.3389/fcvm.2021.719031.

Viability testing to guide myocardial revascularisation in patients with heart failure.

Cahill T, Kharbanda R Indian J Thorac Cardiovasc Surg. 2020; 34(Suppl 3):206-212.

PMID: 33060940 PMC: 7525594. DOI: 10.1007/s12055-017-0637-4.

References

Klem I, Weinsaft J, Bahnson T, Hegland D, Kim H, Hayes B . Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012; 60(5):408-20. PMC: 3424733. DOI: 10.1016/j.jacc.2012.02.070. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Borden W . Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2012; 127(1):e6-e245. PMC: 5408511. DOI: 10.1161/CIR.0b013e31828124ad. View

Lee D, Goldberger J . CMR for sudden cardiac death risk stratification: are we there yet?. JACC Cardiovasc Imaging. 2013; 6(3):345-8. DOI: 10.1016/j.jcmg.2012.12.006. View

Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O . 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm.... Eur Heart J. 2013; 34(29):2281-329. DOI: 10.1093/eurheartj/eht150. View

Yancy C, Jessup M, Bozkurt B, Butler J, Casey Jr D, Drazner M . 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 62(16):e147-239. DOI: 10.1016/j.jacc.2013.05.019. View

Fallavollita J, Heavey B, Luisi Jr A, Michalek S, Baldwa S, Mashtare Jr T . Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2013; 63(2):141-9. PMC: 3954563. DOI: 10.1016/j.jacc.2013.07.096. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M . Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2013; 129(3):e28-e292. PMC: 5408159. DOI: 10.1161/01.cir.0000441139.02102.80. View

Goldberger J, Basu A, Boineau R, Buxton A, Cain M, Canty Jr J . Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014; 129(4):516-26. DOI: 10.1161/CIRCULATIONAHA.113.007149. View

Butler J . The emerging role of multi-detector computed tomography in heart failure. J Card Fail. 2007; 13(3):215-26. DOI: 10.1016/j.cardfail.2006.11.014. View

10.

Schinkel A, Bax J, Poldermans D, Elhendy A, Ferrari R, Rahimtoola S . Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007; 32(7):375-410. DOI: 10.1016/j.cpcardiol.2007.04.001. View

11.

Curtis L, Whellan D, Hammill B, Hernandez A, Anstrom K, Shea A . Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med. 2008; 168(4):418-24. DOI: 10.1001/archinternmed.2007.80. View

12.

Epstein A, DiMarco J, Ellenbogen K, Estes 3rd N, Freedman R, Gettes L . ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002.... Circulation. 2008; 117(21):e350-408. DOI: 10.1161/CIRCUALTIONAHA.108.189742. View

13.

Goldberger J, Cain M, Hohnloser S, Kadish A, Knight B, Lauer M . American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the.... Circulation. 2008; 118(14):1497-1518. View

14.

Ypenburg C, van Bommel R, Delgado V, Mollema S, Bleeker G, Boersma E . Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008; 52(17):1402-9. DOI: 10.1016/j.jacc.2008.06.046. View

15.

Le Polain De Waroux J, Pouleur A, Vancraeynest D, Pasquet A, Gerber B, El Khoury G . Early hazards of mitral ring annuloplasty in patients with moderate to severe ischemic mitral regurgitation undergoing coronary revascularization: the importance of preoperative myocardial viability. J Heart Valve Dis. 2009; 18(1):35-43. View

16.

Boogers M, Van Kriekinge S, Henneman M, Ypenburg C, van Bommel R, Boersma E . Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy. J Nucl Med. 2009; 50(5):718-25. DOI: 10.2967/jnumed.108.060657. View

17.

Djousse L, Driver J, Gaziano J . Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA. 2009; 302(4):394-400. PMC: 2742484. DOI: 10.1001/jama.2009.1062. View

18.

Roes S, Borleffs C, van der Geest R, Westenberg J, Ajmone Marsan N, Kaandorp T . Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging. 2009; 2(3):183-90. DOI: 10.1161/CIRCIMAGING.108.826529. View

19.

Ajmone Marsan N, Westenberg J, Ypenburg C, Delgado V, van Bommel R, Roes S . Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009; 2(11):1245-52. DOI: 10.1016/j.jcmg.2009.07.006. View

20.

Schuetz G, Zacharopoulou N, Schlattmann P, Dewey M . Meta-analysis: noninvasive coronary angiography using computed tomography versus magnetic resonance imaging. Ann Intern Med. 2010; 152(3):167-77. DOI: 10.7326/0003-4819-152-3-201002020-00008. View